Sun Pharma

11.03.2025 • News

Sun Pharma to Acquire Checkpoint Therapeutics

Indian generic drug maker Sun Pharma agreed to acquire US immunotherapy and targeted oncology company Checkpoint Therapeutics for an upfront value of $355 million. The transaction is expected to be completed in the second quarter of 2025 and is subject to customary closing conditions.

07.06.2016 • News

Sun Pharma Sells US Plants to Frontida

04.04.2016 • News

Sun Pharma Buys Novartis Drugs

15.02.2016 • News

Mylan to Buy Sweden’s Meda for $9.9 Billion

12.06.2013 • News

Teva, Sun Pharma to Pay $2.15 Billion to Settle Pfizer Patent Suit

01.06.2013 • News

India's Sun Pharma in Talks to Buy Sweden's Meda for $5-$6 Billion

13.08.2012 • News

India's Sun Pharma Wins over Taro with Higher Offer

12.04.2011 • News

India's Sun Pharma, US Merck in Generics Joint Venture

Top-Feature

Evonik Industries AG

Maximize the Potential of Spent Hydroprocessing Catalysts

CAS

Pioneering End-to-End Green Chemical Production

Ecocool GmbH

Transport Logistic: Ecocool Presents Packaging Solutions for Pharmaceutical Transports

IMCD Deutschland GmbH

Fostering Innovation and Collaboration

Whitepaper

Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.